Treatment of postmenopausal osteoporotic women with parathyroid hormone 1-84 for 18 months improves trabecular bone architecture: A study of iliac crest biopsies using micro-computed tomography.

被引:0
|
作者
Dempster, DW
Moreau, IA
Varela, A
Smith, SY
Ste-Marie, LG
Fox, J
Newman, MK
Recker, RR
机构
[1] Helen Hayes Hosp, W Haverstraw, NY USA
[2] CTBR, Senneville, PQ, Canada
[3] CHUM, Hosp St Luc, Ctr Rech, Montreal, PQ, Canada
[4] NPS Pharmaceut, Salt Lake City, UT USA
[5] Creighton Univ, Omaha, NE 68178 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S98 / S98
页数:1
相关论文
共 14 条
  • [1] Treatment of postmenopausal osteoporotic women with parathyroid hormone 1-84 for 18 months improves trabecular bone architecture: A study of iliac crest biopsies using micro-computed tomography
    Dempster, D. W.
    Fox, J.
    Moreau, I.
    Varela, A.
    Ste-Marie, L. G.
    Newman, M. K.
    Smith, S. Y.
    Recker, R. R.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S74 - S74
  • [2] Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84
    Recker, R. R.
    Bare, S. R.
    Smith, S. Y.
    Varela, A.
    Miller, M. A.
    Morris, S. A.
    Fox, J.
    BONE, 2009, 44 (01) : 113 - 119
  • [3] Treatment of osteoporotic women with parathyroid hormone 1-84 for 18 months improves cancellous bone formation and structure: A bone biopsy study.
    Recker, RR
    Bare, SP
    Miller, MA
    Newman, MK
    Fox, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S97 - S97
  • [4] Longitudinal changes in trabecular and cortical BMD and indices of bone strength assessed by quantitative computed tomography at the hip of postmenopausal osteoporotic women treated with parathyroid hormone (1-84) for 18 months.
    Bogado, C. E.
    Lang, T. F.
    Zanchetta, J. R.
    Mango, A.
    Koyama, A.
    Mathisen, A.
    Fox, J.
    Morris, S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S296 - S296
  • [5] Safety indices from iliac crest biopsies from postmenopausal osteoporotic women after 36 months of treatment with PTH (1-84)
    Recker, R. R.
    Zanchetta, J. R.
    Mautalen, C. A.
    Leib, E. S.
    Greisen, H.
    Morris, S. A.
    Fox, J.
    BONE, 2009, 44 (02) : S431 - S432
  • [6] Treatment of osteoporotic women with parathyroid hormone (1-84) for 24 months improves cancellous bone formation and structure: A bone biopsy study
    Lems, Willem F.
    Geusens, Piet
    Recker, Robert R.
    Bare, Susan P.
    Miller, Michael A.
    Greisen, Hanna
    Fox, John
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S738 - S738
  • [7] Treatment of postmenopausal osteoporotic women with parathyroid hormone (1-84) for 18 months decreases BMD but does not affect indices of bone strength at the distal radius.
    Bogado, C. E.
    Zanchetta, J. R.
    Gordon, C. L.
    Bouxsein, M. L.
    Mathisen, A. L.
    Fox, J.
    Morris, S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S112 - S113
  • [9] EFFECTS OF ROMOSOZUMAB IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AFTER 2 AND 12 MONTHS ASSESSED BY MICRO COMPUTED TOMOGRAPHY AND HISTOMORPHOMETRY ON ILIAC CREST BONE BIOPSIES
    Chavassieuxl, P.
    Chapurlatl, R.
    Roux, J. -P.
    Portero-Muzy, N.
    Garcia, P.
    Brown, J. P.
    Horlait, S.
    Libanati, C.
    Boyce, R.
    Wang, A.
    Grauer, A.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S59 - S59
  • [10] Treatment of osteopenic Rhesus monkeys with parathyroid hormone 1-84 for 16 months improves vertebral trabecular bone quantity and quality.
    Moreau, IA
    Smith, SY
    Guldberg, RE
    Turner, CH
    Newman, MK
    Fox, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S412 - S412